FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
Saved in:
| Title: | FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer. |
|---|---|
| Authors: | Gombos A; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. andrea.gombos@bordet.be.; Université Libre de Bruxelles, Brussels, Belgium. andrea.gombos@bordet.be., Venet D; Université Libre de Bruxelles, Brussels, Belgium.; Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium., Ameye L; Statistical Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium., Vuylsteke P; Medical Oncology, UCLouvain, CHU Namur Site Sainte-Elisabeth, Namur, Belgium.; University of Botswana, Private Bag UB 0022, Gabarone, Botswana., Neven P; Multidisciplinary Breast Center and Department of Gynecology and Obstetrics, UZ Leuven, KU Leuven, Leuven, Belgium., Richard V; Medical Oncology CHU Ambroise Paré, Mons, Belgium., Duhoux FP; Medical Oncology Cliniques Universitaires Saint-Luc, Brussels, Belgium., Laes JF; OncoDNA, Gosselies, Belgium., Rothe F; Université Libre de Bruxelles, Brussels, Belgium.; Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium., Sotiriou C; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium.; Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium., Paesmans M; Statistical Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium., Awada A; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium., Guiot T; Nuclear Medicine, Institut Jules Bordet, Brussels, Belgium., Flamen P; Nuclear Medicine, Institut Jules Bordet, Brussels, Belgium., Piccart-Gebhart M; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium., Ignatiadis M; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium., Gebhart G; Nuclear Medicine, Institut Jules Bordet, Brussels, Belgium. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2021 Sep 21; Vol. 7 (1), pp. 125. Date of Electronic Publication: 2021 Sep 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34548493 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gombos+A%22">Gombos A</searchLink>; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. andrea.gombos@bordet.be.; Université Libre de Bruxelles, Brussels, Belgium. andrea.gombos@bordet.be.<br /><searchLink fieldCode="AU" term="%22Venet+D%22">Venet D</searchLink>; Université Libre de Bruxelles, Brussels, Belgium.; Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Ameye+L%22">Ameye L</searchLink>; Statistical Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Vuylsteke+P%22">Vuylsteke P</searchLink>; Medical Oncology, UCLouvain, CHU Namur Site Sainte-Elisabeth, Namur, Belgium.; University of Botswana, Private Bag UB 0022, Gabarone, Botswana.<br /><searchLink fieldCode="AU" term="%22Neven+P%22">Neven P</searchLink>; Multidisciplinary Breast Center and Department of Gynecology and Obstetrics, UZ Leuven, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Richard+V%22">Richard V</searchLink>; Medical Oncology CHU Ambroise Paré, Mons, Belgium.<br /><searchLink fieldCode="AU" term="%22Duhoux+FP%22">Duhoux FP</searchLink>; Medical Oncology Cliniques Universitaires Saint-Luc, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Laes+JF%22">Laes JF</searchLink>; OncoDNA, Gosselies, Belgium.<br /><searchLink fieldCode="AU" term="%22Rothe+F%22">Rothe F</searchLink>; Université Libre de Bruxelles, Brussels, Belgium.; Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Sotiriou+C%22">Sotiriou C</searchLink>; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium.; Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Paesmans+M%22">Paesmans M</searchLink>; Statistical Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Awada+A%22">Awada A</searchLink>; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Guiot+T%22">Guiot T</searchLink>; Nuclear Medicine, Institut Jules Bordet, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Flamen+P%22">Flamen P</searchLink>; Nuclear Medicine, Institut Jules Bordet, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Piccart-Gebhart+M%22">Piccart-Gebhart M</searchLink>; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Ignatiadis+M%22">Ignatiadis M</searchLink>; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Gebhart+G%22">Gebhart G</searchLink>; Nuclear Medicine, Institut Jules Bordet, Brussels, Belgium. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2021 Sep 21; Vol. 7 (1), pp. 125. <i>Date of Electronic Publication: </i>2021 Sep 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34548493 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41523-021-00331-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 125 Titles: – TitleFull: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gombos A – PersonEntity: Name: NameFull: Venet D – PersonEntity: Name: NameFull: Ameye L – PersonEntity: Name: NameFull: Vuylsteke P – PersonEntity: Name: NameFull: Neven P – PersonEntity: Name: NameFull: Richard V – PersonEntity: Name: NameFull: Duhoux FP – PersonEntity: Name: NameFull: Laes JF – PersonEntity: Name: NameFull: Rothe F – PersonEntity: Name: NameFull: Sotiriou C – PersonEntity: Name: NameFull: Paesmans M – PersonEntity: Name: NameFull: Awada A – PersonEntity: Name: NameFull: Guiot T – PersonEntity: Name: NameFull: Flamen P – PersonEntity: Name: NameFull: Piccart-Gebhart M – PersonEntity: Name: NameFull: Ignatiadis M – PersonEntity: Name: NameFull: Gebhart G IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 09 Text: 2021 Sep 21 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 2374-4677 Numbering: – Type: volume Value: 7 – Type: issue Value: 1 Titles: – TitleFull: NPJ breast cancer Type: main |
| ResultId | 1 |